Spectral Med Inc (EDT) - Total Liabilities
Based on the latest financial reports, Spectral Med Inc (EDT) has total liabilities worth CA$76.79 Million CAD (≈ $55.55 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Spectral Med Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
Spectral Med Inc - Total Liabilities Trend (1992–2024)
This chart illustrates how Spectral Med Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Spectral Med Inc (EDT) total assets.
Spectral Med Inc Competitors by Total Liabilities
The table below lists competitors of Spectral Med Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
EnviTec Biogas AG
XETRA:ETG
|
Germany | €237.48 Million |
|
CERRO DE PASCO RES
F:N8HP
|
Germany | €6.11 Million |
|
Lantronix Inc
NASDAQ:LTRX
|
USA | $45.55 Million |
|
MEDI ASSIST HEALTHCARE SERVICES LIMITED
NSE:MEDIASSIST
|
India | Rs-8.52 Billion |
|
Lubelski Wegiel Bogdanka S.A.
WAR:LWB
|
Poland | zł1.12 Billion |
|
Pruksa Holding Public Company Limited
BK:PSH
|
Thailand | ฿19.02 Billion |
|
Darfon Electronics Corp
TW:8163
|
Taiwan | NT$20.36 Billion |
|
Horizon Oil Ltd
AU:HZN
|
Australia | AU$114.86 Million |
Liability Composition Analysis (1992–2024)
This chart breaks down Spectral Med Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See debt-free asset ratio of Spectral Med Inc to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.11 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.12 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 9.45 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Spectral Med Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Spectral Med Inc (1992–2024)
The table below shows the annual total liabilities of Spectral Med Inc from 1992 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CA$32.87 Million ≈ $23.77 Million |
+51.03% |
| 2023-12-31 | CA$21.76 Million ≈ $15.74 Million |
+49.55% |
| 2022-12-31 | CA$14.55 Million ≈ $10.53 Million |
+94.73% |
| 2021-12-31 | CA$7.47 Million ≈ $5.41 Million |
-15.40% |
| 2020-12-31 | CA$8.83 Million ≈ $6.39 Million |
+405.84% |
| 2019-12-31 | CA$1.75 Million ≈ $1.26 Million |
+187.64% |
| 2018-12-31 | CA$607.00K ≈ $439.09K |
-1.30% |
| 2017-12-31 | CA$615.00K ≈ $444.88K |
-51.88% |
| 2016-12-31 | CA$1.28 Million ≈ $924.49K |
-57.77% |
| 2015-12-31 | CA$3.03 Million ≈ $2.19 Million |
-0.53% |
| 2014-12-31 | CA$3.04 Million ≈ $2.20 Million |
-18.71% |
| 2013-12-31 | CA$3.74 Million ≈ $2.71 Million |
+85.98% |
| 2012-12-31 | CA$2.01 Million ≈ $1.46 Million |
+17.52% |
| 2011-12-31 | CA$1.71 Million ≈ $1.24 Million |
+10.59% |
| 2010-12-31 | CA$1.55 Million ≈ $1.12 Million |
-57.79% |
| 2009-12-31 | CA$3.67 Million ≈ $2.65 Million |
+20.86% |
| 2008-12-31 | CA$3.03 Million ≈ $2.19 Million |
+19.59% |
| 2007-12-31 | CA$2.54 Million ≈ $1.84 Million |
+8.10% |
| 2006-12-31 | CA$2.35 Million ≈ $1.70 Million |
-78.31% |
| 2005-12-31 | CA$10.82 Million ≈ $7.83 Million |
+5.53% |
| 2004-12-31 | CA$10.25 Million ≈ $7.42 Million |
-3.97% |
| 2003-12-31 | CA$10.68 Million ≈ $7.72 Million |
+4.68% |
| 2002-12-31 | CA$10.20 Million ≈ $7.38 Million |
+3.18% |
| 2001-12-31 | CA$9.89 Million ≈ $7.15 Million |
+29.38% |
| 2000-12-31 | CA$7.64 Million ≈ $5.53 Million |
+10.74% |
| 1999-12-31 | CA$6.90 Million ≈ $4.99 Million |
+9.52% |
| 1998-12-31 | CA$6.30 Million ≈ $4.56 Million |
+57.50% |
| 1997-12-31 | CA$4.00 Million ≈ $2.89 Million |
+17.65% |
| 1996-12-31 | CA$3.40 Million ≈ $2.46 Million |
+54.55% |
| 1995-12-31 | CA$2.20 Million ≈ $1.59 Million |
+37.50% |
| 1994-12-31 | CA$1.60 Million ≈ $1.16 Million |
+77.78% |
| 1993-12-31 | CA$900.00K ≈ $651.05K |
+28.57% |
| 1992-12-31 | CA$700.00K ≈ $506.37K |
-- |
About Spectral Med Inc
Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device … Read more